){kind=logo}
)
Loading
AgTech Navigator News
-
The US FDA is currently evaluating the safety, and efficacy claims of Genus PIC’s gene-edited pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS). FDA approval would not automatically trigger commercial rollout in the US or abroad. Regulatory approvals in key pork-export markets remain essential to commercial viability.
-
AI products have become increasingly use-case focused over the last 12 months, believes Feroz Sheikh, chief information and digital officer at Syngenta Group.